HAE - Earnings call transcript Q3 2020 | Haemonetics Corporation

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Ladies and gentlemen, thank you for standing by and welcome to the Haemonetics Third Quarter Fiscal Year 2020 Earnings Conference Call. At this time, all participant lines are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded. [Operator Instructions]

to Guyette, conference Investor like speaker to now Olga today, Relations. would hand over the your I Thank you. Please go ahead, ma’am.

Olga Guyette

I’m Conference Good us morning. Bill and Burke, XXXX CEO; for joining by Webcast. Call Haemonetics Third our Simon, Thank Quarter Fiscal and you our joined today for Chris CFO. Year

from third divestitures. and are basis organic on fiscal will currency, end-of-life results. and XXXX impacts decisions, products we Today, quarter All discuss an and our year-to-date revenue rates exclude growth

and statements, that our results Our to remarks and forward-looking today filings we results. Form factors include materially in differ concerning differ the that anticipated today make could actual from we in will may results filed with X-K periodic is the Information available cause SEC.

quarter to XXXX year-to-date to included we’ll third and on analytical website. and We that call. This the our fiscal Relations with morning, results XXXX guidance tables refer this updated posted posted fiscal Investor information we the our

like excluded Relations the with I adjusted and would that excluded with practices, guidance. of from to same and fiscal Details provided charges posted items, financial been periods income certain we are XXXX, the results the on X-K consistent Investor items best our comparisons and including Form to to remind everyone have website.

release statement and press adjusted website of our results. as and P&L, of summary complete reported our Additionally, cash include well balance sheet, a reconciliations flows as

I’d over like Chris. now, And to it turn to

Christopher Simon

value for are thank everyone, XXXX morning, you Thank delivered earnings our and Good year-to-date Haemonetics and growth. powering quarter drivers you, fiscal strong Olga. joining. performance, as revenue third and

our units third and create long-term X all we and X.X% X.X% Our to year-to-date value. momentum in on with multi-year revenue turnaround track are meaningfully. business building plans We contributing quarter grew the are of

and per earnings due XX% year-to-date, margin quarter revenue up share XX% adjusted year expansion. quarter growth was and the to up prior from $X.XX, Third

with XXX our basis our as portfolio and expanded margin we disciplined strengthen benefits, points remain product to achieve Adjusted productivity operating year-to-date spending. income by continue

Moving in X with and Plasma, revenue seeing second-half XX% third grew to XX.X% remains the for Beginning first In rebound and our underlying growth we months. America, to the grew first The quarter we third the high-single-digits. are and quarter medicines in strong a plasma-based the in in the North business X in months. collection units. demand XX.X% XX.X%

majority of The while showed U.S., gains have especially volumes also the volume our increased in Europe customers course the the in good over the in year. of quarter,

from conversions. benefit We pricing, competitive also and software upgrades

We donor X plasma. to XXX,XXX deliver overall and of X.X the yielding its satisfaction. additional to last approximately $X.X dimensions liters extra million collections call, YES safety enhancement, value NexSys completed total across bringing million over collection procedures, continues all an our efficiency, proposition, yield of since

customers the achieved quarter grew improvements rates device collections they other donor turn and of NexSys in at and the Notably, third customers in rate twice our satisfaction. meaningful

We growth help ability efficiently our remain and in confident Plasma, collect to and plasma. customers its more underlying market safely

We are across the transformational all of incremental NexSys platform. innovation investing components and in

software DMS NexSys. is market as standard. market share. share established itself industry software donor Our our key rapidly management the device of And NexLynk a our is approaching enabler has

year, to we liquids portfolio this exit product the South commoditizing Earlier rationalize and divest our our decision margin-dilutive Carolina liquids strategic business. Union, facility made rapidly a to

revenue negative decision. this a expect result $X as We fourth of impact a approximately million in of quarter

we lower-end collection at the we to and growth XX%, the Plasma volumes of gains. Overall, DMS reaffirming fiscal XXXX the full-year be revenue encouraged by customer and are will of guidance Therefore, range. our are share XX% anticipate for uptick in

our and utilization, Next the growing as Xs TEG product performance Hospital. cartridge and trauma launches quarter up in continue gains XX.X% TEG to improved share in such Revenue indication. on year-to-date. PlateletMapping the is grew new X.X% the and market drive XX% the quarter U.S.

sales major in quarter. investments contributing. with and delivered all pricing largest from TEG XX%, the exceptionally Year-to-date, in U.S., force. third about market benefited our markets strong grew The also globally, results TEG We

are Coramed. growth about and outside as We recent allows excited Xs pursue helps TEG from This also licensed our such new channels profitability. our to the us hospital, acquisition underlying outpatient technology previously of clinics improve the

Transfusion and mid-teens contributing. year-to-date, in management SafeTrace with and the both grew quarter BloodTrack Tx

continue systems We about of hospital Tx of of market. launch support remain to the generation software the the optimistic in information and our growth SafeTrace solutions next the

continues laggard equipment that Salvage Saver cycle in improvement due the vagaries Cell but some disposable a sales to quarter, the showed in distort to capital Cell be comparisons. quarterly

area. are product reaffirming business. fiscal this Overall, are execution end revenue and full the we at growth performance lower in range. momentum sales the to to We our XX% XXXX building guidance XX% and year of drive are in in Hospital expect continuing improvements we of Therefore, for

order where Turning Japan, X.X% Center. up growth was the faced the shortages Revenue with X.X% in to X.X% up year-to-date. product. in due difficulties and declined timing and situation a Blood were our in by to was competitor’s Apheresis revenue in technological X.X% year-to-date. main quarter The customer drivers the quarter

customer situation in to the rollout of global rates, had Improved continued meet market our Universal and higher double dose was collection demand. particularly partially product in share Protocol by success ensure our to team offset Platelet Our proactive Japan. were from this

timing down in were in in whole decline the by quarter X.X% down year-to-date. utilization and America. and offset Favorable quarter North in Japan ongoing the EMEA in was blood order blood Whole X.X% the rates

digits to the and In previously addition, was customer discontinued in software year-to-date down contracts. quarter double due Blood Center

supply. to cost historically compete higher Center we price on compressing to Blood in not chose the sources unfavorable the apheresis and higher expect timing of We fourth alone. order competitive but market a in was margin, due to business and business quarter of This declines lower loss

approximately revenue XXXX. a $XX of and impact fourth fiscal quarter in We million in expect $X the million

X% results. stabilized guidance due be reaffirming Overall, to are and revenue fiscal decline X% end we are strong year action better of the Blood year-to-date Center at XXXX Therefore, expect further performance. to full taking for to we to the

committed Collectively, revenue propelling of to the we XXXX Platelet to X% total guidance our of we launches centric growth range expect business for performance against midpoint at to our customer fiscal our growth Universal The of Therefore, and and Tx SafeTrace TEG strategies. company us. Xs, units executing delivered be NexSys, Protocol X%. remain robust the are

Now, to I’ll Bill. turn the call over

William Burke

everyone. morning, Good

third our program, XX.X%, in adjusted margin basis improving from Our quarter points initiative mix XXX productivity the reduction expansion the improved benefits and was This both reflects gross compared operational year. and savings with from prior product pricing. excellence complexity

the related XX%, with Adjusted NexSys costs depreciation gross prior higher quarter. compared margin capacity, the points I results just expansion our had and were third by factors XXX with also plasma basis the which year in same both device placements offset of to more benefits highlighted. than was improving essentially as year-to-date influencing production We the

million, were quarter with prior operating X% in year. Adjusted third a the decrease expenses compared the of $XX.X

the and as of and As organization. development Partially investments costs a basis in timing. were we leverage mainly initiatives, project result offsetting operating operating sales realized or marketing from points expand continued items research of year. had continue to productivity our our in lower percentage these revenue XX.X% a savings as and Hospital lower we our sales savings were XXX We’ve structure, as prior expenses cost

compared with operating were essentially flat prior the year-to-date expenses Adjusted million, when year. $XXX.X

our revenue development XXX savings were operating and investments by XX.X% sales and As year-to-date points these Similar were year-to-date research of and versus offsetting costs, a basis productivity marketing. of benefits impacted percentage expenses in results down lower revenue, third year. to prior partially adjusted favorably quarter, were our

increase months million, Third increased year-to-date an quarter Adjusted XXXX. year. million income or was compared with income $XXX.X operating XX% fiscal adjusted $XX.X of compared million or X of XX% with million of first operating $XX.X by prior the the $XX.X

margins respectively. XXX quarter XXX operating the and XX.X% Adjusted expansion basis an year in and compared year-to-date, points the prior with were third XX.X% of

operating our came remain improve adjusted from confident efforts be of majority operating adjusted improvements to the our operating spending, guidance fiscal disciplined our gross XXXX expansion with margin. performance and our in our We margin approximately we raised XX%. to While in our remain margin

XX% Our tax XX% income with year. was the third prior quarter in adjusted compared rate

first quarter were the lower the compared tax than of of option rate quarter higher in share adjusted and third exercises first The as income year. the third benefit vestings was the our half half with

was due Our was first with income our exercises fiscal vestings tax option and results. lower year-to-date in fiscal This half rate XXXX. XXXX share XX% tax higher rate compared in to adjusted XX%

adjusted per $X.XX of diluted increase quarter share XX%. with earnings an $X.XX or year, $X.XX compared year, XX%. prior third the was diluted Our or earnings in share $X.XX prior in per an with $X.XX of Adjusted compared $X.XX increase the was year-to-date

per earnings share expense. share net by of the lower adjusted diluted benefit partially Our and lower income tax $X.XX higher interest rate offset a adjusted included count year-to-date from

previous guidance of guidance enabled has per earnings to Our growth since to adjusted in $X.XX fiscal $X.XX implies XX% $X.XX range started from of to highest earnings guidance our to increase share XX% XXXX a with revised diluted us year-to-date compared per our share to fiscal growth performance range $X.XX. XXXX This adjusted fiscal the and when in represents our XXXX. turnaround our diluted we

and in months flow higher million expenditures, in months cash of primarily $XX fiscal capital offset XXXX. Free first costs million compared capital income restructuring partially the was $XX X XXXX by in turnaround higher with lower first before X fiscal XXXX, driven in of the by working fiscal

manufacturing to flow to inventory we the capital of to in Our to levels. the compared million million working increase year-to-date balances, an of results, million. majority $XXX XXXX restructuring in stock in year-to-date, cash before working quarter. new $XXX able $XXX strong free fiscal inflow third our capital $XX cash million of guidance increase devices NexSys million for included Due related The and the the range were flow build disposable a $XX which cash to our outflow high previous and continued guidance safety to cash was despite of turnaround our a was $XXX million with

we average share XXX,XXX repurchase our cash for $XXX Coupled authorization. year-end. XXXX agreement under on with million. current for quarter share X.X the In fiscal at million the executed in of have hand, in a repurchase decrease we an of fiscal the entered we first of XXXX, months half $XX accelerated from $XX the XXXX, approximately X repurchases finished shares repurchased an that million with the share of third about first $XXX price fiscal per approximately fiscal of resulted into repurchase of share XXXX shares of million $XXX million We

margin operating with operations. our strong growth, execution our expansion pleased and and results, efficiency and are we again, revenue of improved reflects Once growth EPS year-to-date quarterly

Chris. I’d the call now, turn like back And to to

Christopher Simon

reinforcing close Thanks, trajectory. Bill. I a want our performance and about few by growth points to

sustainable. growth value our impact to drivers on expansion our market. strategies products that the year-to-date our operational our of the growth and evidence bring strength and value multiyear revenue quarter restructuring make efforts, of Complexity organization and positive P&L to Third additional and having excellence, the the are business and are reduction unit our margin

product products our distinctive. rationalizing portfolio to meet our investment make core prioritizing strategic to are the allocating focus markets We goals, technologies the capabilities on and and us that capital and strengthen that

and We act are position we a committed from of to strength. growth, profitable

about excited these how our transforming our people success are are how We about efforts championing is organization. and

using We have momentum creation. value and drive are it we to

fiscal EPS guidance. operating adjusted Accordingly, margin, our we XXXX are adjusted cash free flow increasing and

We XXXX free quadrupling XXXX doubling of XXXX also income before aspiration our cash fiscal operating and turnaround. fiscal reaffirm flow fiscal adjusted restructuring

and turn today your to joining the call for I’ll questions. you operator for back the Thank

Operator

Instructions] question Petrone with from Our [Operator Anthony first comes Jefferies.

open. line is Your

Anthony Petrone

fourth couple the sort and question, months top-line just just bridge to with first through Chris XXX some Thanks. of mentioned, the implied of from math, margin bridge on just lower our quarter, both margin by It the of there. points morning side. here. guidance Bill, in little little third X quarter the bit basis on so good color a Thanks, as good of versus margin the follow-ups. something guidance the slowdown have then just a end I and and a congratulations of at also year for you but from on top-line, a the of the bit Maybe, standpoint implies, And the Chris, and quarter, range a just the start of

Christopher Simon

for that. Hi, Anthony, Chris. it’s Thanks

I’ll with it turn talk breakdown Bill then start me to margin to the implications. the and through over Let revenue

preferring quarterly, value instead You focus creation. on know longer-term we to guide don’t typically

However, markets we give do full aspire transparency. to the

X think forward. X.X% really what’s all robust point to our of back-solve that guided the businesses obviously, have quarter, we X fourth roll. pretty value underlying the in can to driving to difference we’ve is, speaks for number of straight three you the the the with products. And a range, year-to-date If Our and midpoint

from for the benefitted So will we have annualization, the Plasma point annualize this the which in from meaningfully year. contracts, NexSys at

then, some commoditizing We as that have choice we repeat. in our process remarks, compete which gone help cases not customers forward convert and benefit onetime going software liquids on a through play. to to is in our a upgrade the not to made called will And prepared platform, NexLynk a we out

that for taken called So that out quarter. we’ve we implication out $X million fourth and

by one It’s In the contractual. number large, timing. the of It’s the business. nature order that and that Center previously. and the seen lumpy, business, Blood factor It’s continues, is we’ve

a our have to challenge $X where hit. prepared loss, we specific a also in associated a We we million with price alone, compete chose customer out on that that’s called as remarks, not

on a details margin, is they’re Bill they implication robust Hospital but range. the which growth first get obviously, will And implies really and I’ll show help of revenue that. foremost revenue. to them positive into about the and us for continue factors momentum, But the and back talk the let

William Burke

Anthony. Bill. Hi, It’s

is year, for XX.X%. the prior point XX.X% which our the an adjusted a margins XXX we’re versus in And Haemonetics all-time year. is at So operating high. that quarter for almost basis And improvement were XX.X%, the

Now, points operating a FY course this about over XXXX, if the guidance like up the or XX%. We X,XXX our we’re X of year almost to in period. did to look up back you margins basis X

you’re like million when point about $X at talking margin. the on really a operating is the And you look margin, that

some and just a it we swap that that quarter in quarter, have be upwards X% quarter on particular into next million to at of the off is the So a investments when if of $X look quarter. you timing could slide

margin reflective going So, to longer yeah, is where not operating in that implied that’s QX, that down we’re margin slight there is of is be. but concerned it term, move

Anthony Petrone

helpful. And one the That’s on here follow-ups be would Plasma. maybe

on the latest shortages. IG drug anything as there notices seeing FDA shortage pulled Just you’re we out on

margins, much restructuring been to of believe, target the million to the benefit date? I the So savings, that’s over we’ve much share. few on $XX Thanks years, any $XX update next where how then, And second that there program you to the has Bill, can how that year-to-date of again. is just seen clarify, the are gross million, from just realized

Christopher Simon

Chris. it’s Anthony, Yeah. Thanks.

We’re the organic it had forecasted We’ll into historical what range. average, we X% more which in encouraged now volume gets rebound we which the growth believe would us fully by is a is as on second range. high-single-digits to what see see see half, our we in collection Plasma happen. We towards in the long-term suspect back XX%

that. So we feel about great

there short next, contracts customer that quarter of and both connections. with then playing to quarter. very that role variability enable cetera But is NexSys lots mostly, but compete and entirely, given takes tenders, are to from and There helping puts about not we et feel that. long term feel for, they one the that in and to XX% the exist that we and those And tends about share normalize good, out, great

William Burke

Complexity due savings. you XXX basis of And, operating both could of Anthony, and margin the combination X/Xrds say improvement, Excellence the improvement on that is point that Program Operational Reduction the to the Initiative

Anthony Petrone

Thank you much. so

Operator

Thank you.

James. with Keusch Larry from comes Raymond question next Our

open. is line Your

Lawrence Keusch

everyone. Thanks. Good morning,

you Just and XX% in understand the help difference category? the the X% just disposals starting up us growth on between Plasma, the for could

Christopher Simon

Yeah, it’s Larry, Chris.

and organic sources the liquids, of any collection we good also participate on we the have the in which But We leave from proprietary there don’t and now. customers customers lurch. we’re terms a accordingly. backing growth any volume. going advantage away we’ll side that, At point in So, still we’re have in contracts understand time place, not in seek to in

We also have software.

Software is lumpy. really

challenges there quarter-over-quarter terms the we when and evolved know, of and you we As recognize standards things. accounting have have in

some the support, the involved it annualization of along forecasting. up you are that in but different the for services see, we’ll in contribute overall and it that world, to effects, things combination and In relative elsewhere in than continue the with will our difference U.S. addition, those make does looks and in we include

Lawrence Keusch

Okay.

Is to So however, that of disposals’ half. good the you’re messages, still second X% right? the feel for you in looking underlying obviously growth the about demand and in high-single-digits XX%, those

Christopher Simon

excellent about feel actually We is happen. that role NexSys it. feel that Larry. we right, making And exactly That’s playing, the about excellent

volume. Our the grew customers their in of collection quarter customers our twice in rate NexSys at the other

Lawrence Keusch

alluded other pipeline quick then Perfect. prepared again, ones. NexSys. Chris, X in Okay. your a And against comments, you to

timing but around could to quickly. I’ll the guess, inventory comments my like I inventory. it that behind And be third software working Again trying the is it the in understand, just the on what’s there? increases like looks Sounds But again, right Bill the I’m ask inventory driven, any cap for just and and did if decelerate, issue, math again, quarter.

as forward. really going that I mentioned, we again, think, you NexSys should But about number builds. it’s capital inventory think how

Christopher Simon

Okay.

So Larry, Chris. it’s

On right. the innovation front,

core it’s innovation value So company. drivers we our a agenda, the one of robust have for

product of products. have our We across roadmaps all

think itself, software. which is the donor across X Separately, we there that the have includes management we offering, embedded not software, are is software – device NexSys, about device the dimensions. For our There’s NexLynk. the –

our have kits, service. data that the and this. of customer analytics at harness, and which tech have And includes bottle core the we and support addition, then services, In plastic which we are both disposables is and

are And customers that of America positive standard to our further immediate are whom most the innovate, on And continuing out of in innovating industry. gets large make we now prepared committed that XX our the challenging procedure do we us to all volume for are our and is to of are have shares XX the small software we and as upgrading North all think software, innovate NexLynk. there. we those. of our effect, to called in software, on share. across the process of the XX I We software, That in and to remarks, ourselves having software our

William Burke

I increase, X in months year. an the have happened in think, to this continued we’ve Yes, inventory. of balance inventory the first that most on increase the Larry, of And

the inventory a of inventory. to the stock the and in up of safety flattening So a We low build safety levels. you a a that again, did a was devices And we’ve level, our and see now. at build stock both NexSys in build reasonable out very level were combination in built

of that don’t – you inventory comfortable see that hit obviously Now that that the we’ve increase we’re disposable there. with we’ve level in an balance

inventory. consider to I historical seen reverting have to forward, think back you going we on be Now what can us

You’re not X the type of same that going seen to last we’ve over see months. build the

Lawrence Keusch

Okay. it. Perfect. appreciate Thanks, I guys.

William Burke

Yeah.

Christopher Simon

you. Thank

Operator

Thank you.

from question Dave comes next with Our Securities. JMP Turkaly

line Your is open.

David Turkaly

the guess, at all, twice then at you I if comment grew As your Thanks. share? customers of the convert others, the thoughts as folks? love you of disposables what that see look growth, rate know, you’re that and at The on your to market today Great. if sort you surprises continue to that at customers of could NexSys rate other sort seeing convert, of some double these get implies I’d I we don’t

Christopher Simon

Dave, question. appreciate thanks, the I

I with again, observing annualization, were think, of you and right? make another early aspect hard what as positive experience our adopters worked We adoption the is, the very possible. as this seamless to of cycle

customers We’re confident software device in our they said, when and change, have. it’s they particularly as ability to the change the that. DMS do That’s meaningful help

operating complete curve standard the are and is customers the so, the a And more who and comment set learning benefits a that that have it. doing they in new procedures comes experiencing. there’s converted – So of with I curve learning about

time, confidence proposition in reduction base and the plus NexSys from today. us we look spike XX% the where the that it collected, doing that donor overdraws of said, comfortable million would for at be bit in a the gives be is liters XX% the That a reach in we additional compliance real. and sit entire those XXX,XXX value that I’d collections, probably customer improvement $X.X cycle when satisfaction, not extrapolate To the and something under to

David Turkaly

was add think, the a bought I additional there was the might as color comment beyond follow-up. you side, noticed just that quick I you moving TEG setting. around some on Hospital curious, IP, it Great. that. hospital on I maybe a And Thanks. about and the if any

Christopher Simon

we are about TEG. excited Yeah. Happy to, Yeah, Dave.

out a originator in positive the the that helps really but We’re really from eliminated Coramed, was a our remaining the buyout in. announced near-term, with royalty in relationship we here, we XX% approximating We’ve of that seeing quarter the stage products rates we’ve they’re payments, long-term at in the rights particularly because bought The had nice and growth acceleration, transaction profitability the lifecycle. Coramed, the improve product. the this

us it of scope now for opens does clinics. mobile it can the potential is this what settings. take can really, use. But outpatient to it We up to We take

of which associated mobile So testing, opportunity emergency with and demand think I of think total the that diagnostic we’re expand think form units, over stroke I et where care, all time the seeing product. potential cetera, for to market the has we TEG our viscoelastic

David Turkaly

Thank you.

Operator

you. Thank

comes question from next David Lewis Morgan Our with Stanley.

open. is line Your

Mason Austen

Thanks Hi, taking this is question. my Mason for on for David.

inflected of savings Could see to So think in savings I feeling they XXXX. fiscal we’re similar you And, we down those still cadence? about expected. XXXX of meaningfully loaded? years? quick the next a some in of pretty fiscal a OEP the Are guess, as or a ratable back-half how or talk margins should the couple kind as starting look follow-up, that over you’re in about bit just margin of more tamper expansion Should about trajectory

Christopher Simon

seeing when for specifically more Operational May we FY in to our Excellence, on program we We are program be by in the going ramp XXXX OEP issue savings August in on – early the I’m specific announced about call year. But in guidance our savings. we what earnings in not the so. we’ll talk the started May or So are guidance.

about being you more mentioned it comment And back-ended loaded. the

has specifically. May. bit take chain again, a But attain that savings. those related savings may is manufacturing will of more said a our portion savings be said What we’ve clear nature because haven’t what the done of be little these longer And get to of to business. in We to lot of to, supply the to just that are and those

specifically. I’ll we improvement, on then And speak – margin operating margin

there, else We’re business. in given is at year. improvement, the for XX% we in see should really continue And we are this where to being out confident all that the Operational equal the Program Excellence

Mason Austen

X follow-up, we just NexLynk? largest quick just the using And that confirm can customers are then, fractionators Great. a now as

Christopher Simon

individual privacy know customers, the investment to appreciate going talk just of going there. Thanks. we’re the those out No, to I not respect just we’re about to not important But for Mason. it’s customers, to thesis. question. go I

Mason Austen

thank Right, you.

Operator

comes Our Matson Thank & Instructions] question next Needham Mike you. from [Operator Company. with

Your open. line is

Michael Matson

Good morning. for Thanks taking my questions.

to you’re at any fiscal you looks thoughts underlying giving But be that ask there this and you Street points want benefit It margin the guidance Just basis I point. without large improvement XXXX. get that? the probably is about seems know with leverage just about like. not modeling any operating could additional XXX of restructuring to it some Can contracts with give NexSys. on of

Christopher Simon

won’t it right? Mike, Yeah, be earnings is surprise, quarter third a call. This our

this only we right guidance. We to in about delivering The thing on us intensity velocity that’s appropriate year by with focused are is we’re our finishing and is the deliver and front of implied the prepared that all what’s and that say to income to doubling back X-year XXXX operating intend flow aspiration FY and aspiration original on. XXXX meet an cash of it quadrupling related fiscal free as

Beyond talk May. in that, we’ll

Michael Matson

That’s investments Okay. fine. there whether you’ve adding And reps. the you talk latest the hospital just on can and sales been you’re channel, making or about not maybe then,

Christopher Simon

so our to innovation of It there. investments Yeah, relates made series a we back – agenda. we

and trauma me that for the by U.S., we’re the in and embraced We’re really that. FDA We North excuse indication year the earlier from in U.S. proof – team has setting. excited what seeing really for got

and the globally, some particularly now competitive available product helped is close which U.S. cartridge, PlateletMapping has the gaps, have outside We

uptick any seeing our which X sales what capacity, those capabilities quota think cycle. building product this drive account your than managers that gives we’re product with utilization, XX% in we essentially building in stage growth and and us really relevance representatives, is even get see the and that our at that of utilization. meaningful so focused acceleration but the expansion which the helps right comfortable have period commercial I in we confidence we’re a rate in of And education that the have traditional carrying, on specialists for we base, more helping are and things clinical a hospital combination us commercially we’re The prior both

to as we outside think more So more U.S. and there candidly the refine I is do can this. come; we

that head business now potential just full we’re a have the see that to globally. new of beginning customer-centric unit global We I model. of And think

Michael Matson

you. Thank Great.

Operator

And at I participating. this currently and Ladies showing further call. you. today’s Thank you time. gentlemen, conference Thank am concludes no questions this for

disconnect. now may You

Haemonetics (HAE) 4 Feb 202020 Q3 Earnings call transcript